TrianglePUBLICATIONS · 25639769
131I-metaiodobenzylguanidine with intensive chemotherapy and autologous stem cell transplantation for high-risk neuroblastoma. A new approaches to neuroblastoma therapy (NANT) phase II study.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Biol Blood Marrow Transplant
- Publication date
- 2015 Apr
- First author
- Yanik GA
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Yanik GA
- type
- Author
- name
- Villablanca JG
- type
- Author
- name
- Maris JM
- type
- Author
- name
- Weiss B
- type
- Author
- name
- Groshen S
- type
- Author
- name
- Marachelian A
- type
- Author
- name
- Park JR
- type
- Author
- name
- Tsao-Wei D
- type
- Author
- name
- Hawkins R
- type
- Author
- name
- Shulkin BL
- type
- Author
- name
- Jackson H
- type
- Author
- name
- Goodarzian F
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Yanik GA
- type
- Author
- name
- Villablanca JG
- type
- Author
- name
- Maris JM
- type
- Author
- name
- Weiss B
- type
- Author
- name
- Groshen S
- type
- Author
- name
- Marachelian A
- type
- Author
- name
- Park JR
- type
- Author
- name
- Tsao-Wei D
- type
- Author
- name
- Hawkins R
- type
- Author
- name
- Shulkin BL
- type
- Author
- name
- Jackson H
- type
- Author
- name
- Goodarzian F
- type
- Author
- bibliography ids
- nci-bib-7d567957faaa121bfbccc21f
- book metadata
- content sha256
- 9774624e244b90d0196f0ff1658cf7162bf8b5e4f3c00f6cdb91f329ab892ab5
- document type
- citation
- dois
- 10.1016/j.bbmt.2014.12.008
- electronic publication date
- display
- 2015 Jan 30
- precision
- day
- year
- 2015
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:25639769
- immutable id
- pubmed:25639769@9774624e244b90d0196f0ff1658cf7162bf8b5e4f3c00f6cdb91f329ab892ab5
- journal
- abbreviation
- Biol Blood Marrow Transplant
- issn electronic
- 1523-6536
- issn print
- 1083-8791
- issue
- 4
- name
- Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
- nlm unique id
- 9600628
- pages
- 673-81
- volume
- 21
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 25639769
- provenance
- batch id
- 863b068fe5a07222af6a
- provider
- NCBI PubMed ESummary
- record sha256
- 3d42ea5fb379f56083f519c6525c9eb47e03170025ff2a9744e398e8df45f93e
- response sha256
- 80b1cc99e93fcfceb3e1b12ea433c615b032a2db13a615db7a6e9382c17c5034
- retrieved at
- 2026-09-09T23:47:07.648963+00:00
- publication date
- display
- 2015 Apr
- precision
- month
- year
- 2015
- publication types
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- Research Support, U.S. Gov't, P.H.S.
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- 131I-metaiodobenzylguanidine with intensive chemotherapy and autologous stem cell transplantation for high-risk neuroblastoma. A new approaches to neuroblastoma therapy (NANT) phase II study.
Preserved source evidence · Not medical advice